Legend Biotech Corporation
LEGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $272,330 | $255,058 | $195,053 | $186,522 |
| % Growth | 6.8% | 30.8% | 4.6% | – |
| Cost of Goods Sold | $115,306 | $97,991 | $71,344 | $73,922 |
| Gross Profit | $157,024 | $157,067 | $123,709 | $112,600 |
| % Margin | 57.7% | 61.6% | 63.4% | 60.4% |
| R&D Expenses | $113,148 | $98,302 | $101,924 | $104,432 |
| G&A Expenses | $34,721 | $32,594 | $31,463 | $34,201 |
| SG&A Expenses | $87,328 | $80,646 | $72,432 | $83,126 |
| Sales & Mktg Exp. | $52,607 | $48,052 | $40,969 | $48,925 |
| Other Operating Expenses | $0 | $0 | $0 | -$563 |
| Operating Expenses | $200,476 | $178,948 | $174,356 | $186,995 |
| Operating Income | -$43,452 | -$21,881 | -$50,647 | -$74,395 |
| % Margin | -16% | -8.6% | -26% | -39.9% |
| Other Income/Exp. Net | $4,379 | -$102,917 | -$48,483 | $114,906 |
| Pre-Tax Income | -$39,073 | -$124,798 | -$99,130 | $40,511 |
| Tax Expense | $616 | $582 | $1,786 | $14,227 |
| Net Income | -$39,689 | -$125,380 | -$100,916 | $26,284 |
| % Margin | -14.6% | -49.2% | -51.7% | 14.1% |
| EPS | -0.42 | -1.36 | -1.1 | 0.28 |
| % Growth | 69.1% | -23.6% | -492.9% | – |
| EPS Diluted | -0.44 | -1.36 | -1.1 | 0.28 |
| Weighted Avg Shares Out | 90,203 | 92,068 | 91,881 | 91,426 |
| Weighted Avg Shares Out Dil | 92,318 | 92,068 | 91,881 | 91,426 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,674 | $10,470 | $12,056 | $13,654 |
| Interest Expense | $5,643 | $5,240 | $5,061 | $5,152 |
| Depreciation & Amortization | $5,879 | $5,854 | $5,199 | $6,796 |
| EBITDA | -$33,194 | -$113,722 | -$88,870 | $52,459 |
| % Margin | -12.2% | -44.6% | -45.6% | 28.1% |